GMAT Question of the Day - Daily to your Mailbox; hard ones only

It is currently 15 Nov 2019, 02:38

Close

GMAT Club Daily Prep

Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.

Customized
for You

we will pick new questions that match your level based on your Timer History

Track
Your Progress

every week, we’ll send you an estimated GMAT score based on your performance

Practice
Pays

we will pick new questions that match your level based on your Timer History

Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.

Close

Request Expert Reply

Confirm Cancel

It is not uncommon, while under general anesthesia, for

  new topic post reply Question banks Downloads My Bookmarks Reviews Important topics  
Author Message
TAGS:

Hide Tags

Find Similar Topics 
Verbal Forum Moderator
User avatar
V
Status: Greatness begins beyond your comfort zone
Joined: 08 Dec 2013
Posts: 2428
Location: India
Concentration: General Management, Strategy
Schools: Kelley '20, ISB '19
GPA: 3.2
WE: Information Technology (Consulting)
GMAT ToolKit User Reviews Badge CAT Tests
It is not uncommon, while under general anesthesia, for  [#permalink]

Show Tags

New post 03 Jul 2019, 08:00
5
1
11
00:00
A
B
C
D
E

Difficulty:

  45% (medium)

Question Stats:

71% (02:11) correct 29% (02:24) wrong based on 540 sessions

HideShow timer Statistics

It is not uncommon, while under general anesthesia, for a patient’s heart to stop beating. In these situations, if a catheter hasn’t been set up to allow the surgery team to manually circulate the patient’s blood, two drugs are available for anesthesiologists to restore the breathing process. Each is effective, but the far less expensive drug, Pronofyl, causes severe allergic reactions in approximately 5% of patients, while the far more expensive drug, Rontynyl – rarely covered by insurance plans – does not cause such reactions. This can put an unfair burden on the surgery teams, however, when these stressful situations occur: in many cases, they must decide for an unconscious patient whether to risk an unlikely-but-catastrophic reaction, or create a potentially disastrous financial situation for the patient.

Which of the following, if true, most strengthens the conclusion above?

(A) All anesthesia providers have equal access to Pronofyl and Rontynyl.
(B) Not all insurance plans will cover the full cost of treatments for allergic reactions to drugs taken while under anesthesia.
(C) The patent for Rontynyl will not expire for several years, so the price of Ronyntyl is not expected to decrease for quite some time.
(D) There is no way to predetermine which patients will have an adverse reaction to Pronofyl.
(E) Patients who receive a dose of Rontynyl often require additional post-operative doctor visits to recover from the drug’s potency.

 

This question was provided by Veritas Prep
for the Game of Timers Competition

 



During the Game of Timers competition, the Quote function is not available. Please use the BIG POST REPLY button or just scroll to the bottom of the discussion to post a reply.

_________________
When everything seems to be going against you, remember that the airplane takes off against the wind, not with it. - Henry Ford
The Moment You Think About Giving Up, Think Of The Reason Why You Held On So Long
Most Helpful Expert Reply
Founder
Founder
User avatar
V
Joined: 04 Dec 2002
Posts: 18364
Location: United States (WA)
GMAT 1: 750 Q49 V42
GPA: 3.5
GMAT ToolKit User Premium Member CAT Tests
It is not uncommon, while under general anesthesia, for  [#permalink]

Show Tags

New post 07 Jul 2019, 23:09
1
Official Explanation

OA: D

Reasoning:
The conclusion of this argument is that surgery teams must decide whether to risk a reaction to Pronofyl or to create a financially disadvantageous situation by choosing Rontynyl instead. But note that the word “risk” makes a massive assumption here: we know that some patients have severe allergic reactions to Pronofyl, but the argument assumes that we don’t know which patients have that reaction – that’s where the element of “risk” comes in. If physicians knew ahead of time which patients should not receive Pronofyl and should instead receive Rontynyl, there wouldn’t be any risk in that decision at all. (D) highlights that assumption: if there is no way to predetermine who will have that reaction, then of course there’s an element of risk at play with doctors having to make snap decisions. If (D) were not true – if doctors knew in advance who should receive which drug – the element of risk would not appear, so (D) essentially removes a critical flaw in the argument.

Among the incorrect choices:
  • (A) is incorrect because the conclusion is only that “in many cases” surgery teams need to make this decision, so it is not important that ALL surgery teams have EQUAL access to both drugs; as long as many teams do, the conclusion will still hold.
  • (B) miszes the scope of the decision, which is about the health risk of the allergic reaction vs. the financial risk of Rontynyl.
  • (C) similarly misses the scope of the argument, as the long-term cost of Rontynyl isn’t necessary for the present-tense conclusion (this is happening) to be true.
  • And (E) adds to known information: Rontynyl is already known to be expensive, so additional doctor visits do not advance the conclusion. Plus it is unclear whether insurance would cover those visits or whether those visits would be necessary for Pronofyl. The important component of the conclusion is that surgery teams need to risk health for finances, and we need an answer choice that deals with that concept of risk.



 

This question was provided by Veritas Prep
for the Game of Timers Competition

 


_________________
Most Helpful Community Reply
Manager
Manager
avatar
G
Joined: 30 May 2019
Posts: 109
It is not uncommon, while under general anesthesia, for  [#permalink]

Show Tags

New post Updated on: 03 Jul 2019, 09:05
7
In Strengthen questions, we need to carefully evaluate the argument, e.g. identify premise and conclusion. Here, conclusion says that it is solely the doctors who decide which drug to use and thus bare the consequences of their decision. We need to strengthen this claim. Although A is super tempting since it says that doctors have equal access to both the medicines and thus no comparative advantage, D strengthens to a greater degree. In D, if doctors have no idea if patients are likely to be allergic or not, then doctors play a game of win-lose. Thus, our answer is D

Originally posted by mira93 on 03 Jul 2019, 08:16.
Last edited by mira93 on 03 Jul 2019, 09:05, edited 1 time in total.
General Discussion
Manager
Manager
avatar
S
Joined: 21 Jan 2019
Posts: 100
Re: It is not uncommon, while under general anesthesia, for  [#permalink]

Show Tags

New post 03 Jul 2019, 08:26
1
Quote:
Conclusion talks about the choice the doctors have to make in terms of patient. Our choice should rule out any possibility by which this choice making becomes easier
(A) All anesthesia providers have equal access to Pronofyl and Rontynyl. this statement doesnt strengthen the argument
(B) Not all insurance plans will cover the full cost of treatments for allergic reactions to drugs taken while under anesthesia.Irrelevant
(C) The patent for Rontynyl will not expire for several years, so the price of Ronyntyl is not expected to decrease for quite some time.Irrelevant
(D) There is no way to predetermine which patients will have an adverse reaction to Pronofyl.Correct
(E) Patients who receive a dose of Rontynyl often require additional post-operative doctor visits to recover from the drug’s potency.Irrelevant as talks about a situation after making the choice
Intern
Intern
avatar
S
Joined: 30 May 2017
Posts: 35
Concentration: Marketing, General Management
GPA: 3.96
WE: Engineering (Health Care)
GMAT ToolKit User CAT Tests
Re: It is not uncommon, while under general anesthesia, for  [#permalink]

Show Tags

New post 03 Jul 2019, 08:33
1
It is not uncommon, while under general anesthesia, for a patient’s heart to stop beating. In these situations, if a catheter hasn’t been set up to allow the surgery team to manually circulate the patient’s blood, two drugs are available for anesthesiologists to restore the breathing process. Each is effective, but the far less expensive drug, Pronofyl, causes severe allergic reactions in approximately 5% of patients, while the far more expensive drug, Rontynyl – rarely covered by insurance plans – does not cause such reactions.

Conclusion: This can put an unfair burden on the surgery teams, however, when these stressful situations occur: in many cases, they must decide for an unconscious patient whether to risk an unlikely-but-catastrophic reaction, or create a potentially disastrous financial situation for the patient.
Support this dilemma and that how this dilemma can exist
Which of the following, if true, most strengthens the conclusion above?

(A) All anesthesia providers have equal access to Pronofyl and Rontynyl.
(B) Not all insurance plans will cover the full cost of treatments for allergic reactions to drugs taken while under anesthesia.
(C) The patent for Rontynyl will not expire for several years, so the price of Ronyntyl is not expected to decrease for quite some time.
(D) There is no way to predetermine which patients will have an adverse reaction to Pronofyl.
// This supports that the dilemma is real and that there is no way to predict the effect.
(E) Patients who receive a dose of Rontynyl often require additional post-operative doctor visits to recover from the drug’s potency.
Manager
Manager
User avatar
G
Joined: 22 May 2015
Posts: 126
Re: It is not uncommon, while under general anesthesia, for  [#permalink]

Show Tags

New post 03 Jul 2019, 08:35
So basically doctors have to decide to use Drug A or Drug B. If suppose any one drug was not readily available the choice is clear. There is a dilemma only when both the drugs are readily available. Hence option A fits in perfectly.
_________________
Consistency is the Key
Manager
Manager
avatar
G
Joined: 27 May 2010
Posts: 200
CAT Tests
It is not uncommon, while under general anesthesia, for  [#permalink]

Show Tags

New post Updated on: 03 Jul 2019, 23:53
1
Conclusion is 'This can put an unfair burden on the surgery teams, however, when these stressful situations occur ... they must decide for an unconscious patient whether to risk an unlikely-but-catastrophic reaction, or create a potentially disastrous financial situation for the patient'

(A) All anesthesia providers have equal access to Pronofyl and Rontynyl.
Access to the type of anesthesia does not add to doctors' burden

(B) Not all insurance plans will cover the full cost of treatments for allergic reactions to drugs taken while under anesthesia.
It says 'Not all', so some insurance plans do cover the full cost of treatments. Does not strengthen

(C) The patent for Rontynyl will not expire for several years, so the price of Ronyntyl is not expected to decrease for quite some time.
Patent expiry is not quite relevant.

(D) There is no way to predetermine which patients will have an adverse reaction to Pronofyl.
This would put an additional burden on the doctors. If there is no way to predetermine the adverse reaction, it is tough for the doctors to make a call.

(E) Patients who receive a dose of Rontynyl often require additional post-operative doctor visits to recover from the drug’s potency.
Post-operative visits are not relevant.

Posted from my mobile device
_________________
Please give Kudos if you like the post

Originally posted by prashanths on 03 Jul 2019, 08:36.
Last edited by prashanths on 03 Jul 2019, 23:53, edited 2 times in total.
Manager
Manager
User avatar
G
Joined: 03 Oct 2012
Posts: 159
Location: India
Concentration: Entrepreneurship, Strategy
WE: Brand Management (Pharmaceuticals and Biotech)
Re: It is not uncommon, while under general anesthesia, for  [#permalink]

Show Tags

New post 03 Jul 2019, 08:40
3
1
IMO, the conclusion of this passage is that the dilemma of which drug to use puts an unfair burden on the surgery teams. So whatever increases the burden on the poor surgeons should be the best choice. POE according to my understanding:

(A) All anesthesia providers have equal access to Pronofyl and Rontynyl (Doesn't look like it would increase the quandary of the surgeons. Eliminate)
(B) Not all insurance plans will cover the full cost of treatments for allergic reactions to drugs taken while under anesthesia (Not all insurance plans but some will do? Full costs will not be covered but some costs will be? Too much confusion. Eliminate)
(C) The patent for Rontynyl will not expire for several years, so the price of Ronyntyl is not expected to decrease for quite some time (Haa, gives a good reason for lobbyists to gun for big pharma price regulations not a good reason to increase the dilemma of the surgeons. Eliminate)
(D) There is no way to predetermine which patients will have an adverse reaction to Pronofyl (Well if this is true, the poor surgeons definitely need to worry more since they won't be able to solve their quandary as per the passage. Best choice IMO)
(E) Patients who receive a dose of Rontynyl often require additional post-operative doctor visits to recover from the drug’s potency (This probably gives one more reason to surgeons not to use it. Eliminate)

I hope my answer is correct else it will be such a googly
:facepalm_man: :idontknow: :fingers_crossed:
Manager
Manager
User avatar
S
Joined: 18 Sep 2018
Posts: 100
CAT Tests
Re: It is not uncommon, while under general anesthesia, for  [#permalink]

Show Tags

New post 03 Jul 2019, 08:43
1
IMO D

(A) All anesthesia providers have equal access to Pronofyl and Rontynyl. - Does not matter if some providers has more or less access
(B) Not all insurance plans will cover the full cost of treatments for allergic reactions to drugs taken while under anesthesia. - Cost of treatment for allergic reaction is out of scope
(C) The patent for Rontynyl will not expire for several years, so the price of Ronyntyl is not expected to decrease for quite some time. - Does not matter if the price remain same as it's still expensive
(D) There is no way to predetermine which patients will have an adverse reaction to Pronofyl. - Correct
(E) Patients who receive a dose of Rontynyl often require additional post-operative doctor visits to recover from the drug’s potency. - some add on expense does not matter as the drug is already highly expensive
Director
Director
User avatar
V
Joined: 28 Jul 2016
Posts: 646
Location: India
Concentration: Finance, Human Resources
GPA: 3.97
WE: Project Management (Investment Banking)
Reviews Badge
Re: It is not uncommon, while under general anesthesia, for  [#permalink]

Show Tags

New post 03 Jul 2019, 08:45
1
It is not uncommon, while under general anesthesia, for a patient’s heart to stop beating. In these situations, if a catheter hasn’t been set up to allow the surgery team to manually circulate the patient’s blood, two drugs are available for anesthesiologists to restore the breathing process. Each is effective, but the far less expensive drug, Pronofyl, causes severe allergic reactions in approximately 5% of patients, while the far more expensive drug, Rontynyl – rarely covered by insurance plans – does not cause such reactions. This can put an unfair burden on the surgery teams, however, when these stressful situations occur: in many cases, they must decide for an unconscious patient whether to risk an unlikely-but-catastrophic reaction, or create a potentially disastrous financial situation for the patient.

What may strengthen if we can safely say if surgery team does not if reaction can occur or not.
If they know before hand they can consult patient and tell them.
We should try to find a link that helps set up that link between the statements


Which of the following, if true, most strengthens the conclusion above?

(A) All anesthesia providers have equal access to Pronofyl and Rontynyl. this we can take as an assumption but not having access clearly proves that surgery team will be forced to give other substitute
(B) Not all insurance plans will cover the full cost of treatments for allergic reactions to drugs taken while under anesthesia.no effect of post surgery.. Rather it weakens the argument that cost will be same in both cases
(C) The patent for Rontynyl will not expire for several years, so the price of Ronyntyl is not expected to decrease for quite some time.Irellevant
(D) There is no way to predetermine which patients will have an adverse reaction to Pronofyl.this statement helps up prove that surgery team has no option ut to decide in dire situation
(E) Patients who receive a dose of Rontynyl often require additional post-operative doctor visits to recover from the drug’s potencyIrrelevant
Manager
Manager
avatar
S
Joined: 04 Sep 2016
Posts: 66
Location: Germany
GPA: 3
CAT Tests
Re: It is not uncommon, while under general anesthesia, for  [#permalink]

Show Tags

New post 03 Jul 2019, 08:47
2
Conclusion: This can put an unfair burden on the surgery teams, however, when these stressful situations occur: in many cases, they must decide for an unconscious patient whether to risk an unlikely-but-catastrophic reaction, or create a potentially disastrous financial situation for the patient.

Which of the following, if true, most strengthens the conclusion above?

(A) All anesthesia providers have equal access to Pronofyl and Rontynyl. - a very neutral statement..very partial strengthen at max

(B) Not all insurance plans will cover the full cost of treatments for allergic reactions to drugs taken while under anesthesia. Some do...cover?? sort of weakens then.

(C) The patent for Rontynyl will not expire for several years, so the price of Ronyntyl is not expected to decrease for quite some time. About the future price. Doesnt help us

(D) There is no way to predetermine which patients will have an adverse reaction to Pronofyl. This strengthens. Because if there was a way to determine which patients get a reaction, then we can check with patients before they get the anesthesia ....if they want to choose the expensive one or the one which will give them a reaction

(E) Patients who receive a dose of Rontynyl often require additional post-operative doctor visits to recover from the drug’s potency. Doctor visits to recover are better from the allergy actions? we dont know. Doesnt affect the argument
_________________
Proud Wildling :)


Your Kudos are much appreciated


The three great essentials to achieve anything worthwhile are, first, hard work; second, stick-to-itiveness; third, common sense."
Manager
Manager
avatar
S
Joined: 30 Aug 2018
Posts: 103
Location: India
Concentration: Finance, Accounting
GPA: 3.36
WE: Consulting (Computer Software)
Premium Member
Re: It is not uncommon, while under general anesthesia, for  [#permalink]

Show Tags

New post 03 Jul 2019, 08:48
1
Conclusion : cheap and risky drug vs expensive and safe drug causes confusion..

A) All anesthesia providers have equal access to Pronofyl and Rontynyl. - Does not strengthen/weaken just a fact.
(B) Not all insurance plans will cover the full cost of treatments for allergic reactions to drugs taken while under anesthesia. Out of scope nothing to do with our drugs
(C) The patent for Rontynyl will not expire for several years, so the price of Ronyntyl is not expected to decrease for quite some time. -future prediction not related
(D) There is no way to predetermine which patients will have an adverse reaction to Pronofyl. _correct as this will again put more pressure on the doctors to choose
(E) Patients who receive a dose of Rontynyl often require additional post-operative doctor visits to recover from the drug’s potency.--weakens saying expensive drug is also not safe.
Manager
Manager
avatar
G
Joined: 13 Nov 2018
Posts: 125
Location: India
GMAT 1: 700 Q51 V32
Reviews Badge CAT Tests
Re: It is not uncommon, while under general anesthesia, for  [#permalink]

Show Tags

New post 03 Jul 2019, 08:49
1
Pre-thinking : Doctors need to use two drugs -pronofyl and rontynl-of which former might have reaction in 5% people and latter is not covered by insurance , so doctors are faced with dilemma whether to use pronofyl or rontynl, so we need a statement which will strengthen conclusion


A) All anesthesia providers have equal access to Pronofyl and Rontynyl. -irrelevant
(B) Not all insurance plans will cover the full cost of treatments for allergic reactions to drugs taken while under anesthesia. -out ofscope, not talking about all drugs
(C) The patent for Rontynyl will not expire for several years, so the price of Ronyntyl is not expected to decrease for quite some time.-seems diffcult to eliminte, but it do not tell us about pronofyl
(D) There is no way to predetermine which patients will have an adverse reaction to Pronofyl. -correct OA- as if doctors are aware of patient response to pronofyl, then they will go for rontynl
(E) Patients who receive a dose of Rontynyl often require additional post-operative doctor visits to recover from the drug’s potency.-out of scope
Intern
Intern
avatar
B
Joined: 05 Sep 2018
Posts: 12
GMAT 1: 610 Q44 V30
CAT Tests
Re: It is not uncommon, while under general anesthesia, for  [#permalink]

Show Tags

New post 03 Jul 2019, 08:50
2
It is not uncommon, while under general anesthesia, for a patient’s heart to stop beating. In these situations, if a catheter hasn’t been set up to allow the surgery team to manually circulate the patient’s blood, two drugs are available for anesthesiologists to restore the breathing process. Each is effective, but the far less expensive drug, Pronofyl, causes severe allergic reactions in approximately 5% of patients, while the far more expensive drug, Rontynyl – rarely covered by insurance plans – does not cause such reactions. This can put an unfair burden on the surgery teams, however, when these stressful situations occur: in many cases, they must decide for an unconscious patient whether to risk an unlikely-but-catastrophic reaction, or create a potentially disastrous financial situation for the patient.

Which of the following, if true, most strengthens the conclusion above?


The conclusion here is that "This can put an unfair burden on the surgery teams".
According to the argument the decision to choose between Pronofyl and Ronthnyl is the extra burden for the surgery team. So let us try to find the option that strengthen this linkage.

(A) All anesthesia providers have equal access to Pronofyl and Rontynyl. ------> INCORRECT. We are concerned about the unfair burden (decision on behalf of the patients) on the surgery team. This option is not related to the decision making process.
(B) Not all insurance plans will cover the full cost of treatments for allergic reactions to drugs taken while under anesthesia. -----> INCORRECT. We are not concerned about the cost. The strengthener should be linked to the decision making on behalf of patients.
(C) The patent for Rontynyl will not expire for several years, so the price of Ronyntyl is not expected to decrease for quite some time. ------> Out of scope because the price of Ronythyl in future doesn't have any connection with the linkage mentioned above.
(D) There is no way to predetermine which patients will have an adverse reaction to Pronofyl.----> CORRECT. Suppose there is a method to determine if the patients will have an adverse reaction to Pronofyl. In that situation the surgery team will leave the decision on the patients before they are unconscious. The burden is on surgery team because it has to decide on behalf of the patients. The linkage is strengthen.
(E) Patients who receive a dose of Rontynyl often require additional post-operative doctor visits to recover from the drug’s potency. -----> INCORRECT. We are not concerned about the post-operative situation. Out of Scope
_________________
No Option to DIE. It's DO or DO.
Intern
Intern
avatar
S
Joined: 09 Feb 2019
Posts: 20
Re: It is not uncommon, while under general anesthesia, for  [#permalink]

Show Tags

New post 03 Jul 2019, 08:51
1
Conclusion to Strengthen:
This can put an unfair burden on the surgery teams, however............. they must decide for an unconscious patient whether to risk an unlikely-but-catastrophic reaction, or create a potentially disastrous financial situation for the patient.

(A) All anesthesia providers have equal access to Pronofyl and Rontynyl.
(Not affecting their burden to decide. Even if they dont have an equal access, they still have to decide)
(B) Not all insurance plans will cover the full cost of treatments for allergic reactions to drugs taken while under anesthesia.
(Not affecting their burden to decide. Insurance of allergic treatment is a after thought)
(C) The patent for Rontynyl will not expire for several years, so the price of Ronyntyl is not expected to decrease for quite some time.
(Price is not going to decrease. So price will be high as known, not a new information to strengthen)
(D) There is no way to predetermine which patients will have an adverse reaction to Pronofyl.
(Correct: In case there was a way they would have been out of this unfair burden)
(E) Patients who receive a dose of Rontynyl often require additional post-operative doctor visits to recover from the drug’s potency.
(Post operative costs are Out of concern)
Director
Director
avatar
G
Joined: 22 Nov 2018
Posts: 562
Location: India
GMAT 1: 640 Q45 V35
GMAT 2: 660 Q48 V33
GMAT ToolKit User Premium Member
Re: It is not uncommon, while under general anesthesia, for  [#permalink]

Show Tags

New post 03 Jul 2019, 08:53
1
Summary: two drugs are available for anesthesiologists while each is effective drug Pronofyl (cheap) causes severe allergic reactions in approximately 5% of patients and drug Rontynyl (costly) does not cause such reactions. So doctors must decide whether to risk allergy, or spend more.

Weakener : When doctors are able to decide either due to unavailability of one drug / can predetermine who will get the allergy. If any one is addressed then it strengthens the conclusion.

Which of the following, if true, most strengthens the conclusion above?

(A) All anesthesia providers have equal access to Pronofyl and Rontynyl.Incorrect, though in line with thinking we have a better option in D
(B) Not all insurance plans will cover the full cost of treatments for allergic reactions to drugs taken while under anesthesia. Already given in the stem, hence no new information to strengthen
(C) The patent for Rontynyl will not expire for several years, so the price of Ronyntyl is not expected to decrease for quite some time. Provides the information in future context but no additional support on current situation
(D) There is no way to predetermine which patients will have an adverse reaction to Pronofyl.Correct, strengthen the solution
(E) Patients who receive a dose of Rontynyl often require additional post-operative doctor visits to recover from the drug’s potency. Reiterates the current situation as usage of Rontynyl will lead to financial ruin
_________________
Give +1 kudos if this answer helps..!!
Director
Director
User avatar
P
Joined: 04 Sep 2015
Posts: 662
Location: India
WE: Information Technology (Computer Software)
Premium Member Reviews Badge
Re: It is not uncommon, while under general anesthesia, for  [#permalink]

Show Tags

New post 03 Jul 2019, 08:55
2
It is not uncommon, while under general anesthesia, for a patient’s heart to stop beating. In these situations, if a catheter hasn’t been set up to allow the surgery team to manually circulate the patient’s blood, two drugs are available for anesthesiologists to restore the breathing process. Each is effective, but the far less expensive drug, Pronofyl, causes severe allergic reactions in approximately 5% of patients, while the far more expensive drug, Rontynyl – rarely covered by insurance plans – does not cause such reactions. This can put an unfair burden on the surgery teams, however, when these stressful situations occur: in many cases, they must decide for an unconscious patient whether to risk an unlikely-but-catastrophic reaction, or create a potentially disastrous financial situation for the patient.

Which of the following, if true, most strengthens the conclusion above?

(A) All anesthesia providers have equal access to Pronofyl and Rontynyl.
This is a strong contender for the strengthner but those case where the provider have access to the drug is not the correct because its the doctor who gives the anesthesia and not the supplier/provider and even if the provider is also the doctor then also the stressfull situation would arise but if we have a better choice then this choice can be crossed out for the mentioned reason.
(B) Not all insurance plans will cover the full cost of treatments for allergic reactions to drugs taken while under anesthesia.
Weather of not the plans wil cover the full cost of insurance is also a very mild strengthener to the point the we can not consider this as a strengthener at all because if we measure the risk of high expense vs risk of reaction then the risk of reaction will be taken as heavier and this choice does not consider if the plan consider or partially consider the coverage of the treatment.
(C) The patent for Rontynyl will not expire for several years, so the price of Ronyntyl is not expected to decrease for quite some time.The future price decrease does not justify the situation in hand and for this reason solely it is not a good strengthener.
(D) There is no way to predetermine which patients will have an adverse reaction to Pronofyl.
If there was a way to predetermine which patient will have an adverse reaction to pronofyl then the doctors can test for reaction before adminstring anesthesia and in that case the stressfull situation would not occur at all,meanwhile if there is no way to predetermine then the stressfull situation will occur. thus this is the correct strengthener as it eliminates apotential weakner.
(E) Patients who receive a dose of Rontynyl often require additional post-operative doctor visits to recover from the drug’s potency.
The patients who recieve the expensive drug further have to take further treatment which would increase the price even more but this is not helping on the stressfull situation more but only increasing the stress and not actaully what is leading to the stress and for this reason is out.
Senior Manager
Senior Manager
User avatar
P
Joined: 10 Jan 2017
Posts: 329
Location: India
Reviews Badge CAT Tests
Re: It is not uncommon, while under general anesthesia, for  [#permalink]

Show Tags

New post 03 Jul 2019, 08:55
1
Option D, as if There is no way to predetermine which patients will have an adverse reaction to Pronofyl, than this can put extra pressure on the surgery team to decide which drug to opt for. Hence strengthen the conclusion.
_________________
Good, better, best. Never let it rest. 'Till your good is better and your better is best.
Please hit +1 Kudos if you like my Post.
Manager
Manager
User avatar
S
Status: Victory is never a one time thing.
Joined: 14 Jan 2018
Posts: 57
Location: Oman
Concentration: Marketing, Entrepreneurship
GMAT 1: 590 Q49 V21
GMAT 2: 650 Q47 V33
GPA: 3.8
Re: It is not uncommon, while under general anesthesia, for  [#permalink]

Show Tags

New post 03 Jul 2019, 08:56
This is a very interesting question. The answer doesn't jump at you immediately, but some careful pre-thinking can help you deduce the answer.

The conclusion says that making a decision is burdensome for the surgery team because the pros and cons of both the medicines weigh equally. Any answer that further makes it difficult to choose between the two medicine shall be the correct answer.

Option A plays exactly this role. If they are equally accessible, then again the surgery team has no reason to choose one over the other, making the decision making no less burdensome.
Intern
Intern
avatar
B
Joined: 15 Jun 2019
Posts: 32
Location: Kazakhstan
Schools: Carey '21
GPA: 3.93
Re: It is not uncommon, while under general anesthesia, for  [#permalink]

Show Tags

New post 03 Jul 2019, 08:56
(A) All anesthesia providers have equal access to Pronofyl and Rontynyl. - IMO correct, when doctors have the same amount of different drugs it is more difficult to choose one
(B) Not all insurance plans will cover the full cost of treatments for allergic reactions to drugs taken while under anesthesia. - not relevant
(C) The patent for Rontynyl will not expire for several years, so the price of Ronyntyl is not expected to decrease for quite some time. - it is not relevant, because it says about future situations; but we are concerned about short-term results
(D) There is no way to predetermine which patients will have an adverse reaction to Pronofyl. - good, but still worse than A; if doctors have more Pronofyl than Rontynyl they will probably use the first one
(E) Patients who receive a dose of Rontynyl often require additional post-operative doctor visits to recover from the drug’s potency. - not relevant
GMAT Club Bot
Re: It is not uncommon, while under general anesthesia, for   [#permalink] 03 Jul 2019, 08:56

Go to page    1   2   3   4    Next  [ 75 posts ] 

Display posts from previous: Sort by

It is not uncommon, while under general anesthesia, for

  new topic post reply Question banks Downloads My Bookmarks Reviews Important topics  





Powered by phpBB © phpBB Group | Emoji artwork provided by EmojiOne